生物活性抑制劑是一類具有高生物活性的特殊小分子雜環(huán)化合物,這些小分子在生物體內(nèi)通過氫鍵、疏水作用以及色散力等與特定的抗體及酶相互作用,使相應(yīng)蛋白的二級結(jié)構(gòu)和三級結(jié)構(gòu)發(fā)生變化,從而起到一定的蛋白抑制活性。
試劑列表
貨號 |
cas號 |
品名/規(guī)格純度 |
分子式 |
查詢/購買 |
N824559 |
177355-84-9 |
DBeQ, 99% N,N'-Dibenzyl-2,4-quinazolinediamine, 99% |
C22H20N4 |
購買 |
D824560 |
252017-04-2 |
4-[[3-氯-4-[[(2R)-3,3,3-三氟-2-羥基-2-甲基-1-氧代丙基]氨基]苯基]磺?;鵠-N,N-二甲基苯甲酰胺, 99% (2,4-Dihydroxy-5-isopropylphenyl)5-[(4-methyl-1-piperazinyl)meth yl]-1,3-dihydro-2H-isoindol-2-ylmethanone, 99% |
C19H18ClF3N2O5S |
購買 |
G824562 |
1086062-66-9 |
2,4-二氟-n-[2-甲氧基-5-[4-(4-吡嗪)-6-喹啉]-3-吡啶]苯磺酰胺, 99% GSK-2126458, 99% |
C25H17F2N5O3S |
購買 |
P815933 |
82508-31-4 |
土槿皮乙酸, 分析對照品 Pseudolaric acid B, 分析對照品 |
C23H28O8 |
購買 |
D824563 |
912999-49-6 |
AT-13387, 99% (2,4-dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone, 99% |
C24H31N3O3 |
購買 |
C824564 |
848695-25-0 |
6-氯-9-((4-甲氧基-3,5-二甲基吡啶-2-基)甲基)-9H-嘌呤-2-胺, 99% 6-Chloro-9-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-9H-purin-2-amine, 99% |
C14H15ClN6O |
購買 |
N824565 |
1206101-20-3 |
N-(5-(4-((6-氰基吡啶-3-基)甲氧基)苯基)-[1,2,4]噻唑并[1,5-a]吡啶-2-基)環(huán)丙烷羧酰胺, 99% N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxamide, 99% |
C23H18N6O2 |
購買 |
N824615 |
1197160-78-3 |
N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N’-[4-[4,6-二(4-嗎啉基)-1,3,5-三嗪-2-基]苯基]脲, 99% N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]-urea, 99% |
C32H41N9O4 |
購買 |
N824566 |
1029712-80-8 |
2-氟-N-甲基-4-[7-[(喹啉-6-基)甲基]咪唑并[1,2-B]-[1,2,4]三嗪-2-基]苯甲酰胺, 99% 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, 99% |
C23H17FN6O |
購買 |
T824567 |
300801-52-9 |
(Z)-1-(3-乙基-5-甲氧基-2,3-二羥基并噻唑-2-亞基)丙酮, 99% TG003, 99% |
C13H15NO2S |
購買 |
M824572 |
338967-87-6 |
Mdivi-1, 99% Mdivi-1, 99% |
C15H10Cl2N2O2S |
購買 |
S824573 |
1009298-59-2 |
3-[2,4-雙((3S)-3-甲基嗎啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺, 99% 3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide, 99% |
C25H30N6O3 |
購買 |
T824574 |
1252003-15-8 |
Tubastatin A, 99% Tubastatin A, 99% |
C20H21N3O2 |
購買 |
K824609 |
1469337-95-8 |
K-Ras(G12C) inhibitor 12, 97% K-Ras(G12C) inhibitor 12, 97% |
C15H17ClIN3O3 |
購買 |
K824608 |
1469337-91-4 |
K-Ras(G12C) inhibitor 9, 99% K-Ras(G12C) inhibitor 9, 99% |
C16H21ClIN3O4S |
購買 |
H824614 |
1469338-01-9 |
6H05, 99% 6H05, 99% |
C20H30ClN3O2S3.CF3COOH |
購買 |
R823899 |
877399-52-5 |
3-[(1R)-1-(2,6-二氯-3-氟苯基)乙氧基]-5-[1-(4-哌啶)-1H-吡唑-4-基]-2-吡啶胺, 98% 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine, 98% |
C21H22Cl2FN5O |
購買 |
P824605 |
292605-14-2 |
SB-3CT, 99% 2-[(4-phenoxyphenyl)sulfonylmethyl]thiirane, 99% |
C15H14O3S2 |
購買 |
R824606 |
168273-06-1 |
利莫那班, 99% Rimonabant, 99% |
C22H21Cl3N4O |
購買 |
Z824607 |
667463-62-9 |
(2'Z,3'E)-6-溴靛玉紅-3'-肟, 99% (2'Z,3'E)-6-Bromoindirubin-3'-oxim, 99% |
C16H10BrN3O2 |
購買 |
T824603 |
49671-76-3 |
2-(4-叔丁基苯基)苯并咪唑, 98% 2-(4-tert-butylphenyl)-1h-benzo[d]imidazole, 98% |
C17H18N2 |
購買 |
E824600 |
1395084-25-9 |
4-[(1E)-2-(2-氨基-4-羥基-5-甲基苯基)偶氮]-N-2-吡啶基苯磺酰胺, 98% (E)-4-((2-amino-4-hydroxy-5-methylphenyl)diazenyl)-N-(pyridin-2-yl)benzenesulfonamide, 98% |
C18H17N5O3S |
購買 |
H824599 |
1374601-40-7 |
BRD4770, 98% methyl 2-benzamido-1-(3-phenylpropyl)-1H-benzo[d]imidazole-5-carboxylate, 98% |
C25H23N3O3 |
購買 |
M824598 |
10936341-25-0 |
6-馬來酰亞胺基己酸-N-羥基琥珀酰亞胺酯, 98% 6-Maleimidohexanoic acid N-hydroxysuccinimide ester, 98% |
C35H43N7O11 |
購買 |
M824597 |
159857-81-5 |
馬來酰亞胺基己酰-L-纈氨酸-L-瓜氨酸對氨基芐醇對硝基苯基碳酸脂, 98% Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate, 98% |
C35H43N7O11 |
購買 |
M824596 |
55750-63-5 |
6-(馬來酰亞胺基)己酸琥珀酰亞胺酯, 98% 6-Maleimidohexanoic acid N-hydroxysuccinimide ester, 98% |
C14H16N2O6 |
購買 |
S824595 |
1260907-17-2 |
(4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-A][1,4]苯并二氮雜卓-4-乙酰胺, 99% (4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 99% |
C22H22ClN5O2 |
購買 |
D824594 |
183232-66-8 |
1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-(哌啶-1-基)-1H-吡唑-3-甲酰胺, 99% 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-n-1-piperidinyl-1 h-pyrazole-3-carboxamide, 99% |
C22H21Cl2IN4O |
購買 |
E824593 |
1009817-63-3 |
(3E,5E)-3,5-二[(4-硝基苯基)亞甲基]-1-(1-氧代-2-丙烯-1-基)-4-哌啶酮, 99% (3E,5E)-3,5-Bis[(4-nitrophenyl)methylene]-1-(1-oxo-2-propen-1-yl)-4-piperidinone, 99% |
C22H17N3O6 |
購買 |
T824591 |
1392399-03-9 |
BIX 01294, 99% Trihydrochloride Hydrate, 99% |
C28H38N6O2.3HCl |
購買 |
N824589 |
326914-06-1 |
MHY1485, 98% 4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine, 98% |
C17H21N7O4 |
購買 |
L824616 |
668467-91-2 |
LDN-57444, 97% LDN-57444, 97% |
C17H11Cl3N2O3 |
購買 |
N824585 |
362003-83-6 |
NVP-231, 98% N-[2-(Benzoylamino)-6-benzothiazolyl]tricyclo[3.3.1.13,7]decane-1-carboxamide, 98% |
C25H25N3O2S |
購買 |
R824583 |
162011-90-7 |
羅非昔布, 98% Rofecoxib, 98% |
C17H14O4S |
購買 |
A824581 |
486424-20-8 |
3-氨基-6-[4-[(4-甲基-1-哌嗪基)磺?;鵠苯基]-N-3-吡啶基-吡嗪甲酰胺, 98% AZD-2858, 98% |
C21H23N7O3S |
購買 |
P824577 |
303727-31-3 |
4-(4-氯-3-羥基苯基)-2-苯基-5-(吡啶-4-基)-1H-咪唑, 98% 2-(Phenyl)-4-(3-hydroxy-4-chlorophenyl)-5-(4-pyridyl)-1H-imidazole, 98% |
C20H14ClN3O |
購買 |
中華試劑網(wǎng)(www.exnrwjb.cn)
|
|